ArticleCells2020

Phase I/II Clinical Trial of the Anti-Podoplanin Monoclonal Antibody Therapy in Dogs with Malignant Melanoma.

Satoshi Kamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.